We are live on ! Find out more
IMNM icon

Immunome
IMNM

30 hedge funds and large institutions have $9.34M invested in Immunome in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

93% more capital invested

Capital invested by funds: $4.85M → $9.34M (+$4.5M)

7% more funds holding

Funds holding: 28 → 30 (+2)

2.1% less ownership

Funds ownership: 17.32% → 15.22% (-2.1%)

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

70% less call options, than puts

Call options by funds: $49K | Put options by funds: $163K

Holders
30
Holders Change
+2
Holders Change %
+7.14%
% of All Funds
0.48%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
4
Increased
5
Reduced
7
Closed
2
Calls
$49K
Puts
$163K
Net Calls
-$114K
Net Calls Change
-$114K

Top Buyers

1
Millennium Management
Millennium Management
New York
+$732K
2
HighTower Advisors
HighTower Advisors
Illinois
+$82.3K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$75.5K
4
Renaissance Technologies
Renaissance Technologies
New York
+$38.1K
5
Group One Trading
Group One Trading
Illinois
+$27K

Top Sellers

1
AGM
Alpine Global Management
New York
-$1.72M
2
PCM
Prentice Capital Management
Connecticut
-$324K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$46.5K
4
N
Natixis
France
-$39.1K
5
TRCT
Tower Research Capital (TRC)
New York
-$5.04K
Name Holding Trade Value Shares
Change 		Change in
Stake
PCM
1
Prentice Capital Management
Connecticut
$2.16M -$324K -66,241 -13%
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.87M – – –
AGM
3
Alpine Global Management
New York
$1.83M -$1.72M -352,264 -49%
Millennium Management
4
Millennium Management
New York
$747K +$732K +149,650 New
Bank of Montreal
5
Bank of Montreal
Ontario, Canada
$524K – – –
Geode Capital Management
6
Geode Capital Management
Massachusetts
$405K – – –
Cerity Partners
7
Cerity Partners
New York
$266K – – –
BlackRock
8
BlackRock
New York
$207K -$2.1K -429 -1%
State Street
9
State Street
Massachusetts
$148K – – –
Renaissance Technologies
10
Renaissance Technologies
New York
$144K +$38.1K +7,800 +37%
Royal Bank of Canada
11
Royal Bank of Canada
Ontario, Canada
$139K +$303 +62 +0.2%
MFG
12
Magnus Financial Group
New York
$129K – – –
BIM
13
Baldwin Investment Management
Pennsylvania
$127K – – –
SIAP
14
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
$108K – – –
Northern Trust
15
Northern Trust
Illinois
$83.8K – – –
HighTower Advisors
16
HighTower Advisors
Illinois
$83K +$82.3K +16,818 New
Dimensional Fund Advisors
17
Dimensional Fund Advisors
Texas
$77K +$75.5K +15,433 New
Susquehanna International Group
18
Susquehanna International Group
Pennsylvania
$62.6K -$46.5K -9,513 -43%
Morgan Stanley
19
Morgan Stanley
New York
$60.5K – – –
WA
20
Wealth Architects
California
$55.4K – – –
Group One Trading
21
Group One Trading
Illinois
$38.4K +$27K +5,529 +254%
Simplex Trading
22
Simplex Trading
Illinois
$32K +$2.21K +453 +8%
N
23
Natixis
France
$15K -$39.1K -8,000 -73%
Citadel Advisors
24
Citadel Advisors
Florida
$14.7K +$14.4K +2,940 New
MLA
25
MB, Levis & Associates
Pennsylvania
$11.8K – – –
1
2

IMNM Hedge Fund Activity: Q1 2023 in Review

30 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Immunome (IMNM) for Q1 2023, worth a combined $9.34M — up 93% from $4.85M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new IMNM positions and 2 closed out — a net gain of 2 holders — while 5 added to existing stakes and 7 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $732K. The largest seller was Alpine Global Management, cutting an estimated $1.72M.

  • 30 institutional investors held Immunome (IMNM) as of Q1 2023, up from 28 in Q4 2022.
  • Funds reported $9.34M of Immunome stock for Q1 2023, up 93% quarter-over-quarter.
  • 4 funds opened new Immunome positions in Q1 2023 and 2 closed out, a net change of +2 holders.
  • The largest Immunome buyer in Q1 2023 was Millennium Management, an estimated $732K added.
  • The largest Immunome seller in Q1 2023 was Alpine Global Management, an estimated $1.72M sold.

Based on aggregated 13F filings for Q1 2023.